
Les scanners cérébraux précoces peuvent prédire le pronostic de la SEP
Peer reviewed by Natalie HealeyLast updated by Ashwin BhandariLast updated 25 Jul 2019
Répond aux besoins du patient lignes directrices éditoriales
- TéléchargerTélécharger
- Partager
- Langue
- Discussion
Brain scans of people with early signs of multiple sclerosis can predict the long-term prognosis of the disease.
A 15-year study of people diagnosed with clinically isolated syndrome (CIS), an early indicator of potential multiple sclerosis (MS), suggests MRI technology can predict future disability.
Neurology experts at University College London followed 164 people over 15 years. They found the MRI scans taken when participants were first diagnosed displayed signs of future disease progression. Early spinal cord damage indicated people were much more likely to go on to develop the secondary progressive form of MS, which currently has no treatment.
The team also found an association between lesions seen in the brain at the time of CIS, and a person's physical and cognitive performance later in life.
Dr Wallace Brownlee, from the UCL Institute of Neurology, which carried out the research, said it showed that standard MRIs could help those newly diagnosed with MS make better-informed choices about treatment.
"The way we treat MS right now is we put people on treatment and consider escalating or trying a more intensive treatment if it's not working. But with this, we might be able to identify people at the beginning which might mean a more effective treatment at the outset."
Over 100,000 people live with MS in the UK, and one of the most difficult things about being diagnosed is the uncertainty of the condition. The course MS takes is highly variable with significant differences in terms of how quickly it progresses, how disabled a person may become and how cognitive performance is affected.
Dr Susan Kohlhaas, director of research at the MS Society, said: "For someone newly diagnosed, who gets a list of 14 treatments, who has no information about how their MS might develop, it's really complicated. By identifying key factors that appear very early on and indicate how someone's MS might develop, this study has proved crucial."
Sélection de patients pour Faiblesse et engourdissement des membres

Cerveau et nerfs
Causes de la neuropathie périphérique : du diabète aux vaccins
La neuropathie - également appelée neuropathie périphérique - peut toucher n'importe qui, mais elle est plus susceptible de se développer avec l'âge. Au Royaume-Uni, près d'une personne sur dix âgée de plus de 55 ans en est atteinte. Il existe de nombreuses causes possibles de neuropathie périphérique, des plus courantes aux plus rares.
par Amberley Davis

Cerveau et nerfs
De nouveaux traitements pour la SEP se profilent-ils à l'horizon ?
Au Royaume-Uni, 130 000 personnes vivent avec la sclérose en plaques (SEP). Bien qu'il existe des traitements qui peuvent atténuer et aider à gérer les symptômes, la sclérose en plaques est une maladie incurable. Mais aujourd'hui, un essai innovant tente de trouver de nouveaux traitements qui pourraient révolutionner la prise en charge des personnes atteintes de SEP.
par Ellie Broughton
Poursuivre la lecture ci-dessous
Historique de l'article
Les informations contenues dans cette page ont été évaluées par des cliniciens qualifiés.
25 Jul 2019 | Dernière version

Demandez, partagez, connectez-vous.
Parcourez les discussions, posez des questions et partagez vos expériences sur des centaines de sujets liés à la santé.

Vous ne vous sentez pas bien ?
Évaluez gratuitement vos symptômes en ligne
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.